Deutsche Bank Remains a Sell on AstraZeneca (AZN)

Tip Ranks
2025.11.12 11:26
portai
I'm PortAI, I can summarize articles.

Deutsche Bank analyst Emmanuel Papadakis has maintained a Sell rating on AstraZeneca (AZN) with a price target of £105.00. Papadakis, a 4-star analyst with a 53.29% success rate, focuses on the Healthcare sector. The current analyst consensus on AstraZeneca is a Moderate Buy, with an average price target of £114.97.

Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on AstraZeneca today and set a price target of £105.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.7% and a 53.29% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Sanofi, and Novartis AG.

Currently, the analyst consensus on AstraZeneca is a Moderate Buy with an average price target of p14,197.23.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.